![Jacquelyn Sandell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacquelyn Sandell
Conseiller Juridique Général chez
JOUNCE THERAPEUTICS, INC.
Fortune : 105 441 $ au 31/07/2026
Profil
Jacquelyn Fahey Sandell is currently Secretary & Chief Legal Officer at Jounce Therapeutics, Inc. since 2019 and Chief Legal Officer at Voyager Therapeutics, Inc. since 2023.
Formerly, Ms. Sandell was Associate General Counsel at Millennium Pharmaceuticals, Inc. from 2011 to 2015, Vice President & General Counsel at Vericel Corp., and Senior Corporate Counsel at Genzyme Corp.
from 2005 to 2011.
Education includes undergraduate studies at Duke University and graduate studies at Boston University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 34 799 ( 0,06 % ) | 105 441 $ | 31/07/2026 |
Postes actifs de Jacquelyn Sandell
| Sociétés | Poste | Début |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Conseiller Juridique Général | 17/09/2019 |
| VOYAGER THERAPEUTICS, INC. | Conseiller Juridique Général | 10/07/2023 |
Anciens postes connus de Jacquelyn Sandell
| Sociétés | Poste | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Conseiller Juridique Général | 01/01/2011 |
| VERICEL CORPORATION | Conseiller Juridique Général | - |
Formation de Jacquelyn Sandell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
